Delta
>>23084064
750 Drop, prior to Covid Fuckery.
"KNOWINGLY"
TREASON
CRIMES AGAINT HUMAINTY
Caps, OMR
Interestingly stands forOnline MarketingRockstars Festival.
The OMR Festival, known as the Online Marketing Rockstars Festival (OMR) is one of the world’s largest events for digital marketing and technology. Since its founding in 2011, the annual OMR Festival has taken place in Hamburg, Germany. The organizer of the event is Ramp 106 GmbH; the team of founders includes Philipp Westermeyer, Tobias Schlottke, Christian Müller and Christian Byza.[1]
The OMR Festival is organized into two parallel events: the Expo and Conference.
POTUS to speak at 11
Will he start at 11.11???
NEED TO KNOW, WAS ADAM SHIT ONE OF THE "LAWYERS" BEIND THE CREATION OF the PILOT DE FACTO COURTS ie [DEPENDENCY COURT] THAT REMOVED CRIMINAL DUE PROCESS LAWS TO ALLOW CORRUPT SOCIAL WORKERS AND THEIR VERY OWN COURTS, to ILLEGALLY and UNCONSTITUTIONALLY SEVER PARENTAL RIGHTS, TO TRAFFIC CHILDREN USING GOVERNMENT FUNDING???
When they were granted by CLINTON under the FAKE FAMILY PRESERVATION ACT???
Note: TERMINATION OF PARENTAL RIGHTS HAND CHILDREN OVER TO THE STATES, ALSO SEVERING GRANDPARNENT RIGHTS!!! UNCONSTITUTIONAL GOVERNMENT OVER REACH.
AI Overview
While it is difficult to confirm whether Adam Schiff directly worked on the initial creation of Dependency Courts in California, available information suggestshis involvement in aspects of the juvenile justice system and child welfare in the state, particularly during his time as a state legislator.
Here's a breakdown of his relevant activities:
Chairing a Hearing on Legal Representation: In 1999, as a California State Senator, Adam Schiff chaired a hearing co-sponsored by theJudicial Council's Center for Children and the Courts and the Senate Select Committee on Juvenile Justice.This hearing focused on the right of abused or neglected children to legal representation in Dependency Court.
Juvenile Justice and Child Welfare Legislation: During his time in the state legislature, Schiff authored dozens of bills that were signed into law, including measures related to overhauling state child support laws and providing more tools to county welfare departments to protect foster children.He also authored the Schiff-Cárdenas Juvenile Justice Crime Prevention Act of 2000, which allocated funding to programs aimed at keeping at-risk youth out of prison.
Focus on Protecting Vulnerable Children: Schiff's work as a state legislator included efforts to protect children from online predators and assist law enforcement in solving difficult murder cases.
Important Note: The information provided does not definitively state that Schiff was directly involved in the creation of Dependency Courts in California. It primarily highlights his work on related issues within the juvenile justice and child welfare system.
> Nicole claimed Kubrick told her "Pedophiles run the world"
WRONG
HER DAD WAS ONE OF THE MAIN PLAYERS. She already KNEW.
BORN IN.
Kubrick, as you've pointed out was just a puppet.
>>23084688
KEK
Ok.
Ai says…
THERE’S A BIG GAP BETWEEN WHEN THE FIRST MRNA FLU VACCINE WAS TESTED IN MICE IN THE 1990S AND WHEN THE FIRST MRNA VACCINES FOR RABIES WERE TESTED IN HUMANS IN 2013. WHAT WAS HAPPENING IN THE INTERIM?
The early years of mRNA research were marked by a lot of enthusiasm for the technology but some difficult technical challenges that took a great deal of innovation to overcome.
The biggest challenge was that mRNA would be taken up by the body and quickly degraded before it could “deliver” its message—the RNA transcript—and be read into proteins in the cells.
The solution to this problem came from advances in nanotechnology: the development of fatty droplets (lipid nanoparticles) that wrapped the mRNA like a bubble, which allowed entry into the cells. Once inside the cell, the mRNA message could be translated into proteins, like the spike protein of SARS-CoV-2, and the immune system would then be primed to recognize the foreign protein.
SO, WHAT HAPPENED ONCE THEY FIGURED OUT THIS TECHNOLOGY?
The first mRNA vaccines using these fatty envelopes were developed against the deadly Ebola virus, but since that virus is only found in a limited number of African countries, it had no commercial development in the U.S.
THEN COVID-19 HIT … WHAT HAPPENED THEN?
Remember, the COVID-19 pandemic spurred manufacturers to develop dozens of potential vaccines against SARS-CoV-2 and brought tremendous increases in funding. Some of those vaccines used traditional methods involving adenovirus as the spike protein delivery system—such as the Johnson & Johnson vector vaccine.
Thanks to decades of research and innovation, mRNA vaccine technology was ready. With COVID, this technology got its moment and has proven to be extremely safe and effective. Pfizer’s COVID-19 vaccine is the first mRNA product to achieve full FDA approval in the U.S.
WHAT’S NEXT?
Already, vaccine manufacturers are developing mRNA vaccines to protect against other respiratory viruses such as the flu. Moderna is exploring applications of the technology to protect against HIV. It’s a new era for vaccine technology and production, and a testament to scientific progress and decades of research.
Chris Beyrer, MD, MPH ’91, is the Desmond M. Tutu Professor of Public Health and Human Rights and director of the Center for Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health.
https://publichealth.jhu.edu/2021/the-long-history-of-mrna-vaccines
DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™
October 2,2013at 9:00 AM EDT
PDF Version
Research to focus on antibody production for immune defense
CAMBRIDGE, Mass., October 2, 2013—Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid and reliable way to make antibody-producing drugs to protect against a wide range of known and unknown emerging infectious diseases and engineered biological threats.
Messenger RNA therapeutics™ can be designed to tap directly into the body’s natural processes to produce antibodies without exposing people to a weakened or inactivated virus or pathogen, as is the case with the vaccine approaches currently being tested. As a result, Moderna’s messenger RNA therapeutics™ platform has the potential to speed the development and manufacture of treatments that can produce a safer, more reliable and more robust immune response than existing technologies.
“We are honored to be chosen by DARPA for this important grant, which will greatly accelerate our efforts to develop antibody messenger RNA therapeutics™ to combat a wide range of infectious diseases,” said Stéphane Bancel, president and founding CEO of Moderna. “We were awarded this major grant after an intense and rigorous scientific review, and it is a testament to our team’s progress and to the profound implications of messenger RNA therapeutics™ that our work was funded. We look forward to further expanding the development of our platform into this critically important new therapeutic area.”
This $24.6 million grant could support research for up to 5 years to advance promising antibody- producing drug candidates into preclinical testing and human clinical trials. The company also received a $0.7 million “seedling” grant from DARPA in March to begin work on the project.
https://investors.modernatx.com/news/news-details/2013/DARPA-Awards-Moderna-Therapeutics-a-Grant-for-up-to-25-Million-to-Develop-Messenger-RNA-Therapeutics/default.aspx
> when the hammer falls
>Fuck Lionel
He is not "Anon." That's just EGO, using a platform, to belittle others, while pretending to be "in the Know."
Be Careful Who You Follow….